SCHEMBL7966950

SCHEMBL7966950

Cc1ccc(OC[C@@H](O)CN2CCC(O)(c3cnc4ccccc4c3)CC2)cc1

nearest known ligand 0.56

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.56
USP2 O75604 1/20 0.56
MAPT P10636 2/20 0.53
PRMT5 O14744 1/20 0.47
WDR77 Q9BQA1 1/20 0.47
ABCB1 P08183 6/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
KDM4E B2RXH2 3/20 0.45
GLA P06280 1/20 0.45
CYP2D6 P10635 1/20 0.44
HIF1A Q16665 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7953344 0.92 KDM4E (0.53) MAPTPRMT5WDR77ABCB1L3MBTL1
SCHEMBL7969553 0.92 L3MBTL1 (0.55) TSHRPRMT5WDR77ABCB1L3MBTL1
SCHEMBL7966384 0.90 MAPT (0.53) MAPTPRMT5WDR77ABCB1L3MBTL1
SCHEMBL7969477 0.90 MAPT (0.50) TSHRUSP2MAPTPRMT5WDR77
SCHEMBL7953572 0.90 KMT2A (0.54) TSHRUSP2MAPTPRMT5WDR77
SCHEMBL7965174 0.90 KMT2A (0.52) MAPTPRMT5WDR77ABCB1L3MBTL1
SCHEMBL7969310 0.90 L3MBTL1 (0.51) TSHRPRMT5WDR77ABCB1L3MBTL1
SCHEMBL7953454 0.90 PRMT5 (0.47) TSHRUSP2PRMT5WDR77ABCB1
SCHEMBL7200720 0.90 SMN1; SMN2 (0.57) USP2MAPTPRMT5WDR77ABCB1
SCHEMBL27193282 0.90 SMN1; SMN2 (0.57) USP2MAPTPRMT5WDR77ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6242450-B1 SUBSTITUTED PIPERIDINES ELI LILLY AND COMPANY 2001-06-05 US disclosed
EP-0976746-A1 5-HT1F antagonists ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed
EP-0976747-A2 Use of 5HT-1F receptor antagonists for treating anxiety disorders ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed